ARCHIVES

Avastin Loses Indication for Breast Cancer

This article is from The Cancer Letter archive.

Vol. 37 No. Nov 18 special report | November 18, 2011

Download PDF Visit The Full Archive

Related Articles

DCC Board Approves Concept for Computer System To Reduce Dependence On NIH

June 1, 1990

Federal Coordinating Council On Comparative Effectiveness Research To Hold Meeting

April 10, 2009

Fidaxomicin for CDI Therapy More Cost-Effective Than Vancomycin, Study Says

September 26, 2014

Mammography: Panel Member Quits Over “One-Sided” Document

February 14, 1997

FDA Encourages Study Of Gender Differences

August 6, 1993

Ilex Oncology Buys Symphar, Controls Drug For Bone Mets.

March 2, 2001